A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.
Trisubstituted benzimidazoles have demonstrated potency against Gram-positive and Gram-negative bacterial pathogens. Previously, a library of novel trisubstituted benzimidazoles was constructed for high throughput screening, and compounds were identified that exhibited potency against M. tuberculosi...
Main Authors: | Susan E Knudson, Divya Awasthi, Kunal Kumar, Alexandra Carreau, Laurent Goullieux, Sophie Lagrange, Hélèn Vermet, Iwao Ojima, Richard A Slayden |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3988029?pdf=render |
Similar Items
-
Molecular Design and In-Silico Analysis of Trisubstituted Benzimidazole Derivatives as Ftsz Inhibitor
by: Shankar Thapa, et al.
Published: (2023-01-01) -
Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted Benzimidazoles
by: Rogelio Jiménez-Juárez, et al.
Published: (2020-06-01) -
Synthesis and characterization of novel benzimidazole embedded 1,3,5-trisubstituted pyrazolines as antimicrobial agents
by: Padhy Gopal K., et al.
Published: (2017-01-01) -
Division-cycle in Mycobacterium tuberculosis
by: Ali Akbar Velayati, et al.
Published: (2012-01-01) -
Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles
by: Yeong, Keng Yoon, et al.
Published: (2017)